Looking Back at Life in R&D | GenomeWeb

After 17 years at Lilly, the head of R&D at Lilly Research Laboratories Steven Paul is retiring. While speaking with R&D Directions, Paul says his accomplishments during that time include debuting three new drugs while leading the neuroscience division, redesigning the discovery aspect of the organization, and bringing in new people to keep the pipeline moving.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.